Barclays raised the firm’s price target on RH to $340 from $293 and keeps an Equal Weight rating on the shares. The analyst says RH “continues to set up as one of the most interesting of the cyclical names” and should be well positioned for when demand improves. There were some “encouraging signals” in the Q4 report, but the pace of recovery and the company’s investments “hold us back for now,” the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>